Centessa Pharmaceuticals plc - ADR logo

CNTA

Centessa Pharmaceuticals plc - ADR

$4.31

Earnings Summary

Net Profits
$-54.5Mn

Highlights

Net Profits:

Centessa Pharmaceuticals plc - ADR’s net profit jumped 77.24% since last year same period to $-54.5Mn in the Q1 2022. On a quarterly growth basis, Centessa Pharmaceuticals plc - ADR has generated 81.8% jump in its net profits since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Centessa Pharmaceuticals plc - ADR post its latest quarter earnings

EPS Estimate Current Quarter
-0.7
EPS Estimate Current Year
-0.7

Highlights

EPS Estimate Current Quarter:

Centessa Pharmaceuticals plc - ADR’s earning per share (EPS) estimates for the current quarter stand at -0.7 - a -16.67% fall from last quarter’s estimates.

EPS Estimate Current Year:

Centessa Pharmaceuticals plc - ADR’s earning per share (EPS) estimates for the current year stand at -0.7.

Key Ratios

Key ratios of the Centessa Pharmaceuticals plc - ADR post its Q1 2022 earnings

Earning Per Share (EPS)
-0.6
Return on Assets (ROA)
-0.22
Return on Equity (ROE)
-0.44
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Centessa Pharmaceuticals plc - ADR’s earning per share (EPS) jumped 78.17% since last year same period to -0.6 in the Q1 2022. This indicates that the Centessa Pharmaceuticals plc - ADR has generated 78.17% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Centessa Pharmaceuticals plc - ADR’s return on assets (ROA) stands at -0.22.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Centessa Pharmaceuticals plc - ADR’s return on equity (ROE) stands at -0.44.

Dividend Per Share (DPS):

Centessa Pharmaceuticals plc - ADR declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-16
-0.7
-0.6
14.29%

Company Information

Organisation
Centessa Pharmaceuticals plc - ADR
Employees
2.02K